126 related articles for article (PubMed ID: 34871653)
21. Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
Yoshino S; Nishikawa K; Morita S; Takahashi T; Sakata K; Nagao J; Nemoto H; Murakami N; Matsuda T; Hasegawa H; Shimizu R; Yoshikawa T; Osanai H; Imano M; Naitoh H; Tanaka A; Tajiri T; Gochi A; Suzuki M; Sakamoto J; Saji S; Oka M
Eur J Cancer; 2016 Sep; 65():164-71. PubMed ID: 27501505
[TBL] [Abstract][Full Text] [Related]
22. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans].
Kosaka A; Kuzuoka M; Yamafuji K; Imaizumi A; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1987 Feb; 14(2):516-22. PubMed ID: 3101609
[TBL] [Abstract][Full Text] [Related]
23. Lentinan modulates intestinal microbiota and enhances barrier integrity in a piglet model challenged with lipopolysaccharide.
Wang X; Wang W; Wang L; Yu C; Zhang G; Zhu H; Wang C; Zhao S; Hu CA; Liu Y
Food Funct; 2019 Jan; 10(1):479-489. PubMed ID: 30638239
[TBL] [Abstract][Full Text] [Related]
24. Lentinan as a natural stabilizer with bioactivities for preparation of drug-drug nanosuspensions.
Suo Z; Sun Q; Peng X; Zhang S; Gan N; Zhao L; Yuan N; Zhang Y; Li H
Int J Biol Macromol; 2021 Aug; 184():101-108. PubMed ID: 34119545
[TBL] [Abstract][Full Text] [Related]
25. Structural characterization and antiviral activity of lentinan from Lentinus edodes mycelia against infectious hematopoietic necrosis virus.
Ren G; Xu L; Lu T; Yin J
Int J Biol Macromol; 2018 Aug; 115():1202-1210. PubMed ID: 29704603
[TBL] [Abstract][Full Text] [Related]
26. Effects of lentinan alone and in combination with fluoropyrimidine anticancer agent on growth of human oral squamous cell carcinoma in vitro and in vivo.
Harada K; Itashiki Y; Takenawa T; Ueyama Y
Int J Oncol; 2010 Sep; 37(3):623-31. PubMed ID: 20664931
[TBL] [Abstract][Full Text] [Related]
27. Metabolic degradation of lentinan in liver mediated by CYP450 enzymes and epoxide hydrolase.
Zheng Z; Zhang Y; Liu Y; Wang J; Cui Z; Pan X; Liu Y; Tang W; Wang K
Carbohydr Polym; 2021 Feb; 253():117255. PubMed ID: 33279005
[TBL] [Abstract][Full Text] [Related]
28. Correlation between antitumor activity, molecular weight, and conformation of lentinan.
Zhang L; Li X; Xu X; Zeng F
Carbohydr Res; 2005 Jun; 340(8):1515-21. PubMed ID: 15882854
[TBL] [Abstract][Full Text] [Related]
29. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
Nimura H; Mitsumori N; Takahashi N; Kashimura H; Takayama S; Kashiwagi H; Yanaga K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():106-9. PubMed ID: 16897983
[TBL] [Abstract][Full Text] [Related]
30. A sensitive and rapid radiolabelling method for the in vivo pharmacokinetic study of lentinan.
Zhang Y; Zheng Z; Yang X; Pan X; Yin L; Huang X; Li Q; Shu Y; Zhang Q; Wang K
Food Funct; 2018 Jun; 9(6):3114-3125. PubMed ID: 29876541
[TBL] [Abstract][Full Text] [Related]
31. Preparation of lentinan-calcium carbonate microspheres and their application as vaccine adjuvants.
Liu Z; Yu L; Gu P; Bo R; Wusiman A; Liu J; Hu Y; Wang D
Carbohydr Polym; 2020 Oct; 245():116520. PubMed ID: 32718625
[TBL] [Abstract][Full Text] [Related]
32. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
Kosaka A; Wani T; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
[TBL] [Abstract][Full Text] [Related]
33. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
[TBL] [Abstract][Full Text] [Related]
34. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy.
Qiu Y; Yu Q; Liu Y; Tang J; Wang X; Lu Z; Xu Z; He Q
Pharm Res; 2018 Apr; 35(7):130. PubMed ID: 29700620
[TBL] [Abstract][Full Text] [Related]
35. [Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Kikkawa N; Matsuura N
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1125-30. PubMed ID: 12938267
[TBL] [Abstract][Full Text] [Related]
36. Lentinan Inhibits Tumor Progression by Immunomodulation in a Mouse Model of Bladder Cancer.
Sun M; Bu R; Zhang B; Cao Y; Liu C; Zhao W
Integr Cancer Ther; 2020; 19():1534735420946823. PubMed ID: 32735179
[No Abstract] [Full Text] [Related]
37. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
38. Lentinan produces a robust antidepressant-like effect via enhancing the prefrontal Dectin-1/AMPA receptor signaling pathway.
Bao H; Sun L; Zhu Y; Ran P; Hu W; Zhu K; Li B; Hou Y; Nie J; Gao T; Shan L; Du K; Zheng S; Zheng B; Xiao C; Du J
Behav Brain Res; 2017 Jan; 317():263-271. PubMed ID: 27693847
[TBL] [Abstract][Full Text] [Related]
39. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
Yang H; Tang C; Yin C
Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
[TBL] [Abstract][Full Text] [Related]
40. 3D printed intelligent scaffold prevents recurrence and distal metastasis of breast cancer.
Shi X; Cheng Y; Wang J; Chen H; Wang X; Li X; Tan W; Tan Z
Theranostics; 2020; 10(23):10652-10664. PubMed ID: 32929372
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
